The Ambition of MEET48’s AI-UGC Ecosystem: AI-LLM and Web5 Architecture
GSK shares tumble by most in two years after Zantac ruling
GSK shares dropped by the most in nearly two years after a ruling by the Delaware State Court that will allow jury trials in cases brought by cancer sufferers who say the heartburn drug Zantac caused their condition.